Madison Asset Management LLC Takes $2.65 Million Position in ICU Medical, Inc. $ICUI

Madison Asset Management LLC purchased a new position in ICU Medical, Inc. (NASDAQ:ICUI) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 18,088 shares of the medical instruments supplier’s stock, valued at approximately $2,652,000. Madison Asset Management LLC owned 0.07% of ICU Medical as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently made changes to their positions in ICUI. BlackRock Inc. bought a new stake in ICU Medical during the second quarter valued at $550,250,000. Deutsche Bank AG bought a new position in ICU Medical in the 2nd quarter worth about $4,302,000. Bank of New York Mellon Corp purchased a new stake in shares of ICU Medical in the 2nd quarter valued at about $26,966,000. Oppenheimer Asset Management Inc. purchased a new stake in shares of ICU Medical in the 2nd quarter valued at about $347,000. Finally, Revolve Wealth Partners LLC bought a new stake in shares of ICU Medical during the 2nd quarter valued at about $243,000. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on ICUI. Piper Sandler boosted their price objective on ICU Medical from $163.00 to $195.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Raymond James Financial reaffirmed a “strong-buy” rating and issued a $200.00 target price on shares of ICU Medical in a research note on Friday, August 7th. Zacks Research lowered shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 28th. Sanford C. Bernstein lowered shares of ICU Medical to a “market perform” rating in a research report on Monday, June 15th. Finally, KeyCorp boosted their price target on shares of ICU Medical from $164.00 to $182.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Two research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $192.80.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, insider Ben Sousa sold 2,250 shares of the business’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $178.32, for a total value of $401,220.00. Following the completion of the sale, the insider directly owned 3,076 shares of the company’s stock, valued at $548,512.32. The trade was a 42.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Christian B. Voigtlander sold 8,929 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $182.93, for a total transaction of $1,633,381.97. Following the completion of the sale, the chief operating officer directly owned 37,377 shares of the company’s stock, valued at $6,837,374.61. This represents a 19.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 16,974 shares of company stock worth $3,085,844 in the last 90 days. 2.10% of the stock is owned by company insiders.

ICU Medical Stock Down 2.5%

Shares of ICUI opened at $182.53 on Friday. ICU Medical, Inc. has a 1 year low of $112.50 and a 1 year high of $192.85. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.43 and a quick ratio of 1.21. The stock has a 50 day simple moving average of $160.03 and a two-hundred day simple moving average of $142.86. The firm has a market cap of $4.56 billion, a P/E ratio of 154.69, a P/E/G ratio of 2.37 and a beta of 0.74.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 EPS for the quarter, topping the consensus estimate of $1.91 by $0.46. ICU Medical had a net margin of 1.39% and a return on equity of 7.91%. The firm had revenue of $547.88 million for the quarter, compared to the consensus estimate of $533.44 million. During the same period last year, the firm posted $2.10 earnings per share. The business’s revenue was up .5% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. On average, analysts forecast that ICU Medical, Inc. will post 7.19 earnings per share for the current fiscal year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.